It is generally accepted that cytotoxic CD8+ T cells, following successful priming, recognize tumor-specific (neoantigens) or tumor-associated antigens and exert antitumor function primarily via the release of cytotoxic molecules such as perforin and granzymes (35–37). The gene discussed is CD8A; the disease is neoplasm.